News

UCR experts demystified voter props in online forum

David Danelski — Mon, 30 Sep 2024 00:00:00 -0700

Once again California voters are facing a plethora of state initiatives to decide on issues ranging from increasing penalties for theft and drug offenses to borrowing money to build schools. To help voters better understand the myriad of propositions on the Nov. 5 ballot, the UC Riverside Office of Alumni Engagement and School of Public Policy hosted on Oct. 1 an informative webinar to help voter navigate the complexities of the 2024 California ballot propositions.

Q&A: Gov. Newsom's crackdown on homeless encampments

David Danelski — Fri, 02 Aug 2024 00:00:00 -0700

UC Riverside professors Catherine Gudis and Bruce Link answer questions about Gov. Gavin Newsom's order to dismantle homeless encampments in California.

Dehumanizing rhetoric on immigration harms public health

David Danelski — Fri, 28 Jun 2024 00:00:00 -0700

When top political leaders engage in dehumanizing rhetoric — rather than condemn it — stigmatization of immigrants becomes more legitimized and pervasive in society. The harm goes beyond those seeking entry into the country. It also extends to groups viewed as associated with immigration, such as descendants of immigrants, and to people belonging to ethnic and racial groups with histories of global migration, UCR professor Bruce Link and his co-authors say in the paper published in the Journal of the American Medical Association.

Black Americans: A link between cognitive health and financial instability

Sandra Baltazar Martinez — Wed, 22 May 2024 00:00:00 -0700

Racial minorities develop cognitive impairments, such as Alzheimer’s disease and related dementias at younger ages.

Ernest "Ernie" García, UCR’s first Hispanic graduate, dies

Wed, 10 May 2023 00:00:00 -0700

García, class of 1955, made positive impacts as an educator and as an arts lover.

A new look at ‘The Chicano Experience’

Wed, 21 Sep 2022 00:00:00 -0700

Professor Alfredo Mirandé’s 1985 foundational sociology book has a completely revised second edition.

Girly and a fighter. But are MMA women breaking barriers?

Sandra Baltazar Martinez — Wed, 24 Aug 2022 00:00:00 -0700

Study finds male-dominated MMA is not friendly to gender equality.

Different parental messages about race and ethnicity have different effects on teens’ drug use

Holly Ober — Wed, 04 May 2022 00:00:00 -0700

Study finds promoting appreciation of ethnic-racial heritage has the potential to bolster youth’s internal resources against substance use

Smoking reduces wealth’s tendency to increase life expectancy

Holly Ober — Fri, 08 Apr 2022 00:00:00 -0700

Smoking dominates other factors, including amount of wealth, in shortening lifespan

Professionals are trending in a left and liberal direction; on most issues blue collar workers are not

Holly Ober — Fri, 14 Jan 2022 00:00:00 -0800

Both groups still agree on some important issues and race has little effect

UCR joins Big Brothers Big Sisters in new virtual mentoring program

Sandra Baltazar Martinez — Tue, 07 Sep 2021 00:00:00 -0700

Born from the pandemic, College Bigs, will count on nearly 150 UCR students to work with local high school mentees.

What UC Riverside scientists have to say about vaccines, variants, and antibodies

Iqbal Pittalwala — Wed, 03 Mar 2021 00:00:00 -0800

Immunity generated by vaccination is better than immunity from an actual infection, says an expert

Experts weigh in on whether COVID-19 is here to stay

Iqbal Pittalwala — Wed, 17 Feb 2021 00:00:00 -0800

COVID-19 is far from beaten. Vaccines may not be the ultimate panacea to haul us out of the pandemic crisis. In the future, will outbreaks of SARS-CoV-2, the virus that causes COVID-19, arrive in waves every winter? Might COVID-19 never go away? Experts at the University of California, Riverside, weigh in.

Too much hype, too soon?

Iqbal Pittalwala and John Warren — Tue, 10 Nov 2020 00:00:00 -0800

The news arrived Monday that the world has been awaiting since spring: a vaccine has been developed that shows a high degree of efficacy in late-stage trials: 90%. That puts it in the company of effective vaccines such as for measles, and well beyond what the medical community hoped for in efficacy. Among UCR scientists, as everywhere, the news of the vaccine developed by the drugmakers Pfizer and BioNTech was welcomed.

‘The Cost of Free Shipping’ lifts curtain on Amazon

Holly Ober — Tue, 03 Nov 2020 00:00:00 -0800

A new book alleges worker exploitation at Amazon, and shows how communities are resisting it

A look at graduation celebrations — at home

Wed, 08 Jul 2020 00:00:00 -0700

Photos show how two students commemorated their undergraduate journeys.